Stay updated on XIGDUO XR Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the XIGDUO XR Safety and Efficacy Clinical Trial page.

Latest updates to the XIGDUO XR Safety and Efficacy Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov page revision identifier changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe Xigduo XR postmarketing surveillance study record is displayed, including its study design, participant criteria, safety and effectiveness measures, South Korean locations, and completed status.SummaryDifference38%

- Check21 days agoChange DetectedThe displayed ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check28 days agoChange DetectedAn NIH-wide banner announces transition updates and says NIH content may use “Super Intelligence” in place of “Artificial Intelligence”.SummaryDifference1%

- Check35 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe site's footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to XIGDUO XR Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XIGDUO XR Safety and Efficacy Clinical Trial page.